Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Clinical Practices in the Treatment of Arterial Hypertension in Portugal

Clinical Practices in the Treatment of Arterial Hypertension in Portugal Am J Cardiovasc Drugs 2010; 10 Special Issue 1: 1-2 EDITORIAL 1175-3277/10/0001-0001/$49.95/0 ª 2010 Adis Data Information BV. All rights reserved. Clinical Practices in the Treatment of Arterial Hypertension in Portugal Pedro von Hafe Hospital de Sa˜o Joa˜o, Faculdade de Medicina da Universidade do Porto, Porto, Portugal Arterial hypertension is the most common risk factor for blockers were prescribed to only 18.9% and 16.2% of patients [5] cardiovascular morbidity and mortality, and its incidence has with hypertension, respectively. The proportion of patients been increasing as a result of an ageing population and an in- with hypertension receiving monotherapy in Portugal thus creasing prevalence of overweight and obesity. Portugal has a appears to be still quite high, and the use of calcium antagonists high incidence of stroke (cerebrovascular accident; CVA), which is lower than is seen in other European countries. One of the [1] accounts for 15.1% of deaths in the country, and several epi- reasons behind these findings may be Portuguese physicians’ demiological studies have shown the association of arterial hyper- knowledge of guidelines for the treatment of arterial hyper- tension as a risk factor for CVA. The treatment of hypertension tension. The present study highlights certain gaps in http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png American Journal of Cardiovascular Drugs Springer Journals

Clinical Practices in the Treatment of Arterial Hypertension in Portugal

Hafe, Pedro
American Journal of Cardiovascular Drugs , Volume 10 (1) – Oct 1, 2012
Download PDF
2 pages

Loading next page...
 
/lp/springer-journals/clinical-practices-in-the-treatment-of-arterial-hypertension-in-212iH7H9Vf

References (7)

Publisher
Springer Journals
Copyright
Copyright © 2010 by Adis Data Information BV
Subject
Medicine & Public Health; Cardiology; Pharmacotherapy; Pharmacology/Toxicology
ISSN
1175-3277
eISSN
1179-187X
DOI
10.2165/1153640-S0-000000000-00000
Publisher site
See Article on Publisher Site

Abstract

Am J Cardiovasc Drugs 2010; 10 Special Issue 1: 1-2 EDITORIAL 1175-3277/10/0001-0001/$49.95/0 ª 2010 Adis Data Information BV. All rights reserved. Clinical Practices in the Treatment of Arterial Hypertension in Portugal Pedro von Hafe Hospital de Sa˜o Joa˜o, Faculdade de Medicina da Universidade do Porto, Porto, Portugal Arterial hypertension is the most common risk factor for blockers were prescribed to only 18.9% and 16.2% of patients [5] cardiovascular morbidity and mortality, and its incidence has with hypertension, respectively. The proportion of patients been increasing as a result of an ageing population and an in- with hypertension receiving monotherapy in Portugal thus creasing prevalence of overweight and obesity. Portugal has a appears to be still quite high, and the use of calcium antagonists high incidence of stroke (cerebrovascular accident; CVA), which is lower than is seen in other European countries. One of the [1] accounts for 15.1% of deaths in the country, and several epi- reasons behind these findings may be Portuguese physicians’ demiological studies have shown the association of arterial hyper- knowledge of guidelines for the treatment of arterial hyper- tension as a risk factor for CVA. The treatment of hypertension tension. The present study highlights certain gaps in

Journal

American Journal of Cardiovascular Drugs – Springer Journals

Published: Oct 1, 2012

There are no references for this article.